For female M1 patients, although median survival was lower in Hospital B (13.8 months, 95% CI: 10.7–17.5) than in Hospital A (17.9 months, 95% CI: 13.6–22.2), this difference did not reach statistical significance ( p = 0.086).
← all excerpts
Exploration of Fully-Automated Body Composition Analysis Using Routine CT-Staging of Lung Cancer Patients for Survival Prognosis.
1
0.0860
0.0860